Tubeless Insulin Pump Market share to grow at 25% CAGR from 2017 to 2024

The research report “Tubeless Insulin Pump Market Size By Component (Pod/Patch, Remote, Others), By Distribution Channel (Hospitals, Pharmacies, e-Commerce, Others), Regional Outlook (U.S., Canada, Germany, UK, Spain, Italy, France, China, Japan, India, South Korea, Australia, Brazil, Mexico, South Africa, Saudi Arabia), Technology Development, Competitive Landscape & Forecast, 2017 – 2024” by Global Market Insights, Inc. says, Tubeless Insulin Pump Market size is set to exceed USD 2 billion by 2024.

Rising number of diabetic and obese patients coupled with introduction of advanced pump will serve as high impact rendering factors for the tubeless insulin pump market growth.

Advent of new technologies in continuous glucose monitoring without the need for daily insulin injection doses will stimulate business growth over the forecast years. Growing adoption of minimally invasive insulin delivery methods should improve patient compliance.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/2032

Inadequate reimbursement coverage and high long-term cost associated with tubeless insulin pump will hamper its adoption in emerging economies. Compliance to insulin therapy may reduce owing to high maintenance therapy cost.

The pods/patches market should witness more than 20% CAGR over the coming years. Regular replacement of pods and high usage frequency will drive the escalated demand for these products.
Tubeless insulin pump remote should grow in parallel with the pods segment. Although the replacement rate of remotes is not as high as that of pods, their initial capital requirement is higher. Increasing sales of new tubeless insulin pump will fuel the significant growth of the remote market.

Distribution of tubeless insulin pump through e-commerce platforms has become the most popular medium. In 2016, e-commerce held the market share of over 50%, valuing more than USD 250 million. This online platform will witness a significant growth over the forecast period.

Browse key industry insights spread across 130 pages with 66 market data tables & 8 figures & charts from this 2017 report Tubeless Insulin Pump Market in detail along with the table of contents at:

https://www.gminsights.com/industry-analysis/tubeless-insulin-pump-market

Distribution through hospitals is less preferred medium because of the high cost of tubeless insulin pump. However, many private hospitals have recently started offering tubeless insulin pump at affordable prices, augmenting the industry growth.

U.S. tubeless insulin pump market valued over USD 200 million in 2016 and anticipated to grow significantly over the coming years. Switching of insulin pump user from tubed to tubeless should be the major growth rendering factor. Moreover, increasing adoption of tubeless pump by first time users will fuel regional industry growth.

Germany accounted for more than 20% of overall regional revenue share, owing to increasing number of diabetic patients and advanced healthcare system. Growing adoption of advanced technology will drive rapid industry grow over the forecast years.

Japan tubeless insulin pump market accounted for largest regional revenue share owing to its growing trend to adopt advanced technology. Rising per capita income of diabetic patients and high healthcare expenditure will promote tubeless insulin pump market growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2032

China should witness lucrative growth in terms of revenue over the forecast period. Factors such as economic growth, large unaddressed diabetic population, rising disposable income, and improving healthcare facilities will propel business growth.

Brazil tubeless insulin pump market is projected to grow at 18% CAGR of over the forecast period. Availability of tubeless insulin pump in recent years will stimulate steady business expansion.
Some of the companies operating in tubeless insulin pump market are Insulet Corporation, Johnson & Johnson, Medtrum Technologies, Roche Holding, Cellnovo Group, Spring Health Solution, Debiotech, CeQur, Valeritas, and Abbott Diabetes Care.

New product launches and geographical expansion will primarily drive the industry. Key industry participants will strive to strengthen their position in this competitive market by adoption these strategies.

Browse Related Reports:

Antidiabetics Market Size By Product (Insulin [Rapid Acting, Long Acting, Premixed, Short Acting, Intermediate Acting], Alpha-Glucosidase Inhibitors, Biguanides, Sulphonylureas, GLP-1 Agonist, Meglitinides, DPP-4 Inhibitors, SGLT-2, Thiazolodinediones), By Application (Type I Diabetes, Type II & Other), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023

https://www.gminsights.com/industry-analysis/antidiabetics-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com

This release was published on openPR.